Winch Advisory Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Winch Advisory Services’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-27	Closed	–	–	299
2017 Q1	$0	Hold	27	–	–	﹤0.01%	288
2016 Q4	$0	Buy	+27	New	+$525	﹤0.01%	266

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Winch Advisory Services's AMPH Position: Q2 2017 in Review

Winch Advisory Services sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2017, closing a stake of 27 shares.

Winch Advisory Services first reported a position in AMPH in Q4 2016 and held it in 2 quarters. The position peaked at $0 in Q1 2017. 108 funds tracked by Wall St. Rank hold AMPH as of Q2 2017.

Winch Advisory Services reported no remaining Amphastar Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Winch Advisory Services sold 27 Amphastar Pharmaceuticals shares in Q2 2017.
Winch Advisory Services first reported a position in Amphastar Pharmaceuticals in Q4 2016 and held it in 2 quarters.
Winch Advisory Services's Amphastar Pharmaceuticals position peaked at $0 in Q1 2017.
108 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2017.

Based on Winch Advisory Services's 13F filing for Q2 2017, filed 7 Aug 2017.